Previous Chapter Chapter 36: Impact of the PROactive Study on the Treatment of Type 2 Diabetes Next Chapter

By: Decision Resources Inc

In: The SAGE Handbook of Healthcare

Chapter 36: Impact of the PROactive Study on the Treatment of Type 2 Diabetes

  • Citations
  • Add to My List
  • Text Size

Impact of the PROactive Study on the Treatment of Type 2 Diabetes
Impact of the proactive study on the treatment of type 2 diabetes
Introduction: Promising Results in the Recent Proactive Study

Type 2 diabetes is a chronic and progressive disease that is frequently linked with long-term microvascular events that cause morbidity (neuropathy, nephropathy, retinopathy, micro-angiopathy) as well as macrovascular events that cause morbidity and mortality (coronary artery disease, stroke, peripheral vascular disease). Moreover, type 2 diabetes is the primary cause of end-stage renal disease worldwide. The life-threatening complications of this disease constitute a significant unmet medical need worldwide, particularly because the prevalence of type 2 diabetes has soared in recent years as a result of changing eating habits and lifestyles.

The therapeutic goals with every type 2 ...

Looks like you do not have access to this content.

Login

Don’t know how to login?

Click here for free trial login.

Back to Top

Copy and paste the following HTML into your website